We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TCI:NYSETranscontinental Realty Investors, Inc. Analysis

Data as of 2026-06-02 - not real-time

$38.01

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Transcontinental Realty Investors (TCI) is trading around $38, comfortably above its 20‑day ($36.65) and 50‑day ($36.78) simple moving averages, while still lagging the 200‑day average of $44.49, signaling a short‑term bounce within a longer‑term bearish framework. Technical momentum looks modestly positive – the MACD line sits above its signal line and the histogram is expanding, and the RSI at 54 indicates the stock is neither overbought nor oversold. Volatility is elevated at roughly 46% over the past 30 days, and beta of 0.68 suggests the stock moves less than the market, yet the high price swings amplify risk. Fundamentals are strained: a trailing PE of 34.9 exceeds the industry average of 31.9, while the price‑to‑book ratio of 0.39 places the market price far below book value, hinting at a valuation disconnect. Debt is a major concern – a debt‑to‑equity ratio of 24.5 and total debt of $212 M dwarf the $9.5 M cash balance, and free cash flow is deeply negative at –$10 M. Recent earnings underscore the weakness, with Q1 net income collapsing to $0.168 M (≈$0.02 EPS) from $4.6 M a year earlier, confirming deteriorating profitability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bullish MACD and price above short‑term SMAs suggest limited upside potential
  • Elevated volatility and thin trading volume increase price uncertainty
  • Recent earnings drop raises caution despite technical support

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Persistently high leverage and negative free cash flow strain financial health
  • PE multiple above industry peers without earnings growth
  • Resistance near $44.20 and lack of dividend income limit upside appeal

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Book‑value discount offers some cushion but unlikely to offset debt burden
  • Structural earnings weakness and declining profit margins
  • Sector cyclicality and regulatory exposure add long‑run uncertainty

Key Metrics & Analysis

Financial Health

Revenue Growth2.80%
Profit Margin18.94%
P/E Ratio34.9
ROE1.16%
ROA-0.43%
Debt/Equity24.45
P/B Ratio0.4
Op. Cash Flow$1.6M
Free Cash Flow$-10100125
Industry P/E31.9

Technical Analysis

TrendBearish
RSI54.1
Support$34.10
Resistance$44.20
MA 20$36.65
MA 50$36.78
MA 200$44.49
MACDBullish
VolumeIncreasing
Fear & Greed Index92.8

Valuation

GradeFair
TypeValue

Risk Assessment

Beta0.68
Volatility45.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.